Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_assertion type Assertion NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_head.
- NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_assertion description "[Here, using a bigenic mouse model system combining mutant oncogenic NRAS(Q61K) (constitutively active RAS) or mutant activated CDK4(R24C/R24C) (prevents binding of CDK4 by kinase inhibitor p16(INK4A)) with an epidermis-specific knockout of the nuclear retinoid X receptor alpha (RXR?(ep-/-)) results in increased melanoma formation after chronic ultraviolet-B (UVB) irradiation compared with control mice with functional RXR?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_provenance.
- NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_assertion evidence source_evidence_literature NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_provenance.
- NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_assertion SIO_000772 25189354 NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_provenance.
- NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_assertion wasDerivedFrom befree-2016 NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_provenance.
- NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_assertion wasGeneratedBy ECO_0000203 NP1216932.RA9lm-GF-mHx3ZE2f-RNfu7raWQpJbA8RD7N54qbNH4Iw130_provenance.